Skip to content
Clinical Trials – home

Sanare spol. s r.o.

Verified siteinfo

Slovakia Mudr. Pribulu 2, 089 01 Svidnik, Slovakia

  • 1 trial recruiting
  • Chronic spontaneous urticaria · Dermatitis atopic · Hidradenitis
  • Adults and children

About Specializations

Sanare spol. s r.o. in Svidnik, Slovakia specialises in clinical trials of conditions such as Chronic spontaneous urticaria, Dermatitis atopic, Hidradenitis, Psoriasis, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases

At Sanare spol. s r.o. in Svidnik, Slovakia, research in immune system diseases focuses on chronic inflammatory conditions that affect the skin and quality of life. The studies are mainly designed to test new therapies, compare treatment options, and assess longer-term safety in people living with persistent immune-mediated disorders.

  • Chronic spontaneous urticaria and chronic urticaria studies evaluating symptom control and treatment effectiveness
  • Atopic dermatitis trials exploring better ways to reduce inflammation and itching
  • Hidradenitis suppurativa research focused on improving disease management and long-term safety

This therapeutic area includes efforts to improve day-to-day symptom relief, measure how well treatments work over time, and support more durable care options for patients with ongoing immune-related skin disease.

Skin and Connective Tissue Diseases

The Dermatovenerologicka ambulancia at this clinic also contributes to studies in skin and connective tissue diseases, with a strong emphasis on chronic dermatologic conditions. The research is aimed at evaluating new treatment approaches, comparing them with established therapies, and improving outcomes for both adults and children.

  • Moderate to severe chronic plaque psoriasis in pediatric patients
  • Nonsegmental vitiligo studies assessing repigmentation and tolerability
  • Chronic venous ulcers research testing wound healing and recovery support

Across these trials, the site is helping assess whether emerging therapies can improve skin appearance, wound closure, and overall disease control in conditions that often require long-term management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Mudr. Pribulu 2089 01 SvidnikSlovakia
Recruiting now
1 trial
Conditions studied
6
Partner status
Verified site

More sites in SvidnikSlovakia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

11 clinical trials

Psoriasis

Recruiting

Study on Tildrakizumab and Etanercept for Children Aged 6 to 17 with Moderate to Severe Plaque Psoriasis

Registered drug
Countries:SlovakiaSlovakia
  • Participants:0–17 years
  • Substances:Etanercept
  • Sponsor:Sun Pharmaceutical Industries Limited

Dermatitis atopic

Not recruiting

Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

Investigational
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Skin ulcer

Not recruiting

Study on the Effectiveness of Allo-APZ2-CVU for Patients with Long-Term, Non-Healing Venous Leg Ulcers

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic skin-derived ABCB5-POSITIVE dermal mesenchymal stromal cells
  • Sponsor:Rheacell GmbH & Co. KG

Study Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Omalizumab
  • Sponsor:Curateq Biologics Private Limited

Vitiligo

Not recruiting

Study of ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Pfizer Inc.

Dermatitis atopic

Not recruiting

Study of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Dermatitis atopic

Not recruiting

Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Hidradenitis

Not recruiting

Study on the Effectiveness of AVTX-009 for Treating Moderate to Severe Hidradenitis Suppurativa in Patients

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:AVTX-009
  • Sponsor:Avalo Therapeutics Inc.

Study of remibrutinib for long-term treatment of adult patients with chronic spontaneous urticaria who completed previous remibrutinib studies

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

Study on the Effectiveness and Safety of Remibrutinib Compared to Placebo and Omalizumab in Adults with Chronic Spontaneous Urticaria Uncontrolled by Antihistamines

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Omalizumab
  • Sponsor:Novartis Pharma AG

Hidradenitis

Not recruiting

Study on Long-Term Use of Spesolimab for Patients with Hidradenitis Suppurativa Who Completed a Previous Spesolimab Study

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Spesolimab
  • Sponsor:Boehringer Ingelheim Espana S.A.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.